Role of reactive oxygen species in angiotensin II: Induced receptor activator of nuclear factor-κB ligand expression in mouse osteoblastic cells

Molecular and Cellular Biochemistry

Volumn 396, Issue 1-2, 2014, Pages 249-255

  Zhang, Yanqiu ^a,b   Zhang, Yongtao ^a,c   Kou, Jianqiang ^c   Wang, Chunsheng ^a   Wang, Kunzheng ^a  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN SHIYOU UNIVERSITY   (China)

^c QINGDAO UNIVERSITY   (China)

Author keywords

Angiotensin II; ERK1 2; NAD(P)H oxidase; Osteoblast; RANKL; Reactive oxygen species

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; CYTOCHROME B; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUTROPHIL CYTOSOL FACTOR 67K; OSTEOCLAST DIFFERENTIATION FACTOR; P22(PHOX) PROTEIN, MOUSE; PHOSPHOPROTEIN; PYRIDINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TNFSF11 PROTEIN, MOUSE;

ANIMAL; CELL LINE; DOSE RESPONSE; DRUG EFFECTS; GENETICS; METABOLISM; MOUSE; OSTEOBLAST; UPREGULATION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANIMALS; CELL LINE; CYTOCHROME B GROUP; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIDAZOLES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; NADPH OXIDASE; OSTEOBLASTS; PHOSPHOPROTEINS; PYRIDINES; RANK LIGAND; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; UP-REGULATION;

EID: 84907591171     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2160-x     Document Type: Article

References (22)

1. Kwak EJ, Lee YS, Choi EM (2012) Effect of magnolol on the function of osteoblastic MC3T3-E1 cells. Mediators Inflamm 2012:1-7
2. Manolagas SC (1998) The role of IL-6 Type cytokines and their receptors in boneaa. Ann N Y Acad Sci 840:194-204
3. Vanderpluijm G, Most W, Vanderweepals L, Degroot H, Papapoulos S, Lowik C (1991) Two distinct effects of recombinant human tumor necrosis factor-a on osteoclast development and subsequent resorption of mineralized matrix. Endocrinology 129:1596-1604
4. Walsh MC, Choi Y (2003) Biology of the TRANCE axis. Cytokine Growth Factor Rev 14:251-263
5. Lacey D, Timms E, Tan H-L, Kelley M, Dunstan C, Burgess T, Elliott R, Colombero A, Elliott G, Scully S (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176
6. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337-342
7. Paul M, Mehr AP, Kreutz R (2006) Physiology of local renin-angiotensin systems. Physiol Rev 86:747-803
8. Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, Morishita R (2008) Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 22:2465-2475
9. Sabanai K, Tsutsui M, Sakai A, Hirasawa H, Tanaka S, Nakamura E, Tanimoto A, Sasaguri Y, Ito M, Shimokawa H (2008) Genetic disruption of all NO synthase isoforms enhances BMD and bone turnover in mice in vivo: involvement of the renin-angiotensin system. J Bone Miner Res 23:633-643
10. Izu Y, Mizoguchi F, Kawamata A, Hayata T, Nakamoto T, Nakashima K, Inagami T, Ezura Y, Noda M (2009) Angiotensin II type 2 receptor blockade increases bone mass. J Biol Chem 284:4857-4864
11. Liu YY, Yao WM, Wu T, Xu BL, Chen F, Cui L (2011) Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts. J Bone Miner Metab 29:149-158
12. Garcia P, Schwenzer S, Slotta J, Scheuer C, Tami A, Holstein J, Histing T, Burkhardt M, Pohlemann T, Menger M (2010) Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation - role of a local renin-angiotensin system. Br J Pharmacol 159:1672-1680
13. Kaneko K, Ito M, Fumoto T, Fukuhara R, Ishida J, Fukamizu A, Ikeda K (2011) Physiological function of the angiotensin AT1a receptor in bone remodeling. J Bone Miner Res 26:2959-2966
14. Asaba Y, Ito M, Fumoto T, Watanabe K, Fukuhara R, Takeshita S, Nimura Y, Ishida J, Fukamizu A, Ikeda K (2009) Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res 24:241-250
15. Liu J-J, Li D-L, Zhou J, Sun L, Zhao M, Kong S-S, Wang Y-H, Yu X-J, Zhou J, Zang W-J (2011) Acetylcholine prevents angiotensin II-induced oxidative stress and apoptosis in H9c2 cells. Apoptosis 16:94-103
16. Pan Q, Yang X-H, Cheng Y-X (2009) Angiotensin II stimulates MCP-1 production in rat glomerular endothelial cells via NAD (P) H oxidase-dependent nuclear factor-kappa B signaling. Braz J Med Biol Res 42:531-536
17. Bai XC, Lu D, Liu AL, Zhang ZM, Li XM, Zou ZP, Zeng WS, Cheng BL, Luo SQ (2005) Reactive oxygen species stimulates receptor activator of NF-κB ligand expression in osteoblast. J Biol Chem 280:17497-17506
18. De Giusti VC, Garciarena CD, Aiello EA (2009) Role of reactive oxygen species (ROS) in angiotensin II-induced stimulation of the cardiac Na+/HCO3- cotransport. J Mol Cell Cardiol 47:716-722
19. Hatton R, Stimpel M, Chambers T (1997) Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J Endocrinol 152:5-10
20. Tanifuji C, Suzuki Y, Geot WM, Horikoshi S, Sugaya T, Ruiz-Ortega M, Egido J, Tomino A (2005) Reactive oxygen species-mediated signaling pathways in angiotensin II-induced MCP-expression of proximal tubular cells. Antioxid Redox Signal 7:1261-1268
21. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH (2005) Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD (P) H oxidase in RVLM. Am J Physiol Heart Circ Physiol 288:H2271-H2279
22. Chen JR, Shankar K, Nagarajan S, Badger TM, Ronis MJ (2008) Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-κB ligand signaling cascade. J Pharmacol Exp Ther 324:50-59